It has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors to induce cells to produce a variety of antiviral proteins, inhibit virus reproduction in cells, and improve immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Pharmacology: Recombinant human interferon α2b has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors to induce cells to produce a variety of antiviral proteins, inhibit viral reproduction in cells, and improve immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells. Toxicology: Acute toxicity test: The product was injected intraperitoneally and intravenously into mice at doses of 1.5×109IU/kg and 1.5×108IU/kg, respectively, which are 105 and 104 times the therapeutic dose for humans. No acute poisoning symptoms occurred and no animals died. Long-term toxicity test: The product was injected intramuscularly into rats at a dose of 1.5×107IU/kg

Broad-spectrum antiviral activity, inhibition of tumor cell proliferation, and enhancement of immune function, including enhancement of the phagocytic function of macrophages, enhancement of the cytotoxicity of lymphocytes to target cells, and enhancement of the function of natural killer cells

This product has the effects of broad-spectrum antiviral, inhibiting tumor cell proliferation and improving immune function. Improving immune function includes enhancing the phagocytic effect of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

It has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors to induce cells to produce a variety of antiviral proteins, inhibit virus reproduction in cells, and improve immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Pharmacology: Recombinant human interferon α2b has broad-spectrum antiviral, anti-tumor, cell proliferation inhibition and immune function enhancement effects. Interferon binds to cell surface receptors to induce cells to produce a variety of antiviral proteins, inhibit viral reproduction in cells, and improve immune function, including enhancing the phagocytic function of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells. Toxicology: Acute toxicity test: The product was injected intraperitoneally and intravenously into mice at doses of 1.5×109IU/kg and 1.5×108IU/kg, respectively, which are 105 and 104 times the therapeutic dose for humans. No acute poisoning symptoms occurred and no animals died. Long-term toxicity test: The product was injected intramuscularly into rats at a dose of 1.5×107IU/kg

A derivative of methylxanthine, a bronchodilator, relaxes bronchial smooth muscle by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma.

Nucleoside antiviral drugs. After entering the cell, this product is rapidly phosphorylated to a monophosphate compound, and then becomes a triphosphate compound through the action of cellular kinase. Its phosphorylation in cells infected with cytomegalovirus is faster than that in normal cells. Ganciclovir can competitively inhibit DNA polymerase and incorporate into the DNA of viruses and host cells, thereby inhibiting DNA synthesis. This product has a stronger inhibitory effect on viral DNA polymerase than host cell polymerase. In animal experiments, this product has teratogenic, carcinogenic, immunosuppressive effects and reproductive system toxicity.